Liposomal Bupivacaine in Total Knee Arthroplasty

NCT02426164 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Could not receive facility approval

Conditions

Pain, Postoperative
Arthroplasty, Replacement, Knee
Osteoarthritis

Interventions

DRUG: Liposomal bupivacaine
DRUG: bupivacaine HCl, morphine, epinephrine, methylprednisolone

Sponsor

Miller Orthopedic Specialists

Collaborators

[object Object]
[object Object]